TNF-α is a predictor of insulin resistance in human pregnancy

Diabetes

Volumn 51, Issue 7, 2002, Pages 2207-2213

  Kirwan, John P ^a   Hauguel De Mouzon, Sylvie ^b   Lepercq, Jacques ^b   Challier, Jean Claude ^c   Huston Presley, Larraine ^a   Friedman, Jacob E ^d   Kalhan, Satish C ^a   Catalano, Patrick M ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

^b INSTITUT COCHIN   (France)

^c université Paris Cité   (France)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; GESTATIONAL AGE; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; PLACENTA LOCALIZATION; PREDICTION AND FORECASTING; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0036307159     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.7.2207     Document Type: Article

References (45)

1. Facilitated anabolism in late pregnancy: Some novel maternal compensations for accelerated starvation
2. Carbohydrate metabolism in pregnancy. XVII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids in late normal pregnancy
3. Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids
4. Insulin action during pregnancy: Studies with the euglycemic clamp technique
5. Longitudinal changes in body composition and energy balance in lean women with normal and abnormal glucose tolerance during pregnancy
6. Maternal carbohydrate metabolism and its relationship to fetal growth and body composition
7. Role of gestational hormones in the induction of insulin resistance
8. Carbohydrate and lipid metabolism during normal pregnancy: Relationship to gestational hormone action
9. Endocrine disorders in pregnancy
10. Insulin signaling and action in fat cells: Associations with insulin resistance and type 2 diabetes
11. Control of energy homeostasis and insulin action by adipocyte hormones: Leptin, acylation stimulating protein, and adiponectin
12. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation
13. Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans
14. Prenatal leptin production: Evidence that fetal adipose tissue produces leptin
15. Muscle damage impairs insulin stimulation of IRS-1, P13-kinase, and Akt-kinase in human skeletal muscle
16. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance
17. Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia
18. Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: Relationship to endogenous glucose production and peripheral tissue glucose uptake
19. Effects of pregnancy and exercise on concentrations of the metabolic markers tumor necrosis α and leptin
20. Tumor necrosis factor α during human pregnancy and labor: Maternal plasma and amniotic fluid concentration and release from intrauterine tissues
21. Circulating bioactive tumor necrosis factor-α, tumor necrosis factor-α receptors, fibronectin, and tumor necrosis factor-α inducible cell adhesion molecule VCAM-1 in uncomplicated pregnancy
22. Circulating levels of immunoreactive cytokines in women with preeclampsia
23. Positional cloning of the mouse obese gene and its human homologue
24. Leptin directly alters lipid partitioning in skeletal muscle
25. Direct antidiabetic effect of leptin through triglyceride depletion of tissues
26. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy
27. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus
28. Criteria for screening tests for gestational diabetes
29. Estimating body composition in late gestation: A new hydration constant for body total body water
30. Clinically useful estimates of insulin sensitivity during pregnancy: Validations studies in women with normal glucose tolerance and gestational diabetes mellitus
31. Glucose clamp technique: A method for quantifying insulin secretion and resistance
32. 2 consumption, lactate and ammonia production
33. Calculation of substrate turnover rate in stable isotope tracer studies
34. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
35. Umbilical cord leptin and neonatal body composition
36. Glucose-induced release of tumor necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus
37. The role of tumor necrosis factor (TNF)-α resistance in obesity and insulin resistance
38. Tumor necrosis factor alpha inhibits signaling from the insulin receptor
39. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates
40. TNF-α impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells
41. 307 via distinct pathways
42. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes
43. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): Evidence for increased serine/threonine phosphorylation in pregnancy and GDM
44. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
45. Lipid metabolism in pregnancy. II. Postheparin lipolytic activity and hypertriglyceridemia in the pregnant rat